BK virus in solid organ transplant recipients

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Hirsch, H H ^a,b   Randhawa, P ^c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

BK virus; Guideline; Kidney; Polyomavirus; Transplantation; Virus

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CALCINEURIN INHIBITOR; CIDOFOVIR; CYCLOSPORIN; IMMUNOGLOBULIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEIC ACID; PREDNISONE; QUINOLONE DERIVATIVE; RAPAMYCIN; TACROLIMUS; VIRUS ANTIBODY;

ACUTE GRAFT REJECTION; ADJUVANT THERAPY; ANTIBODY RESPONSE; BK VIRUS; BLOOD SAMPLING; BONE MARROW SUPPRESSION; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDARTERITIS; FIBROSIS; GLOMERULITIS; GRAFT RECIPIENT; HEMOLYSIS; HEPATITIS; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; IRIDOCYCLITIS; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; LOW DRUG DOSE; MAINTENANCE THERAPY; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PNEUMONIA; POLYOMAVIRUS ASSOCIATED NEPHROPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINITIS; REVIEW; RHEUMATOID ARTHRITIS; RISK; RISK FACTOR; T LYMPHOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; URINALYSIS; VASCULAR NECROSIS; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BIOPSY; BK VIRUS; HUMANS; ORGAN TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIRUS REPLICATION;

EID: 72949088222     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02904.x     Document Type: Review

References (125)

1. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999 67 : 103 109.
2. Binet I, Nickeleit V, Hirsch HH et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999 67 : 918 922.
3. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002 347 : 488 496.
4. Ramos E, Drachenberg CB, Portocarrero M et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002 : 143 153.
5. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986 315 : 230 234.
6. Bedi A, Miller CB, Hanson JL et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995 13 : 1103 1109.
7. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003 3 : 611 623.
8. Elidemir O, Chang IF, Schecter MG, Mallory GB. BK virus-associated hemorrhagic cystitis in a pediatric lung transplant recipient. Pediatr Transplant 2007 11 : 807 810.
9. Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 2008 41 : 11 18.
10. Friedman DP, Flanders AE. MR Imaging of BK virus encephalitis. AJNR Am J Neuroradiol 2006 27 : 1016 1018.
11. Hix JK, Braun WE, Isada CM. Delirium in a renal transplant recipient associated with BK virus in the cerebrospinal fluid. Transplantation 2004 78 : 1407 1408.
12. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005 41 : 354 360.
13. Crowder CD, Gyure KA, Drachenberg CB et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant 2005 5 : 1151 1158.
14. Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005 79 : 1277 1286.
15. Gross PA, Barrett TL, Dellinger EP et al. Purpose of quality standards for infectious diseases.Infectious Diseases Society of America. Clin Infect Dis 1994 18 : 421.
16. Büchen-Osmond C. International Committee on Taxonomy of Viruses Database (ICTVdB). 2008. Available from : http://www.ncbi.nlm.nih.gov/ICTVdb/. Accessed November 5, 2009.
17. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008 319 : 1096 1100.
18. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F, Girones R. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001 75 : 10290 10299.
19. Weinreb DB, Desman GT, Amolat-Apiado MJ, Burstein DE, Godbold JH Jr., Johnson EM. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006 34 : 201 203.
20. Gosert R, Rinaldo CH, Funk GA et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008 205 : 841 852.
21. Chen Y, Trofe J, Gordon J, Autissier P, Woodle ES, Koralnik IJ. BKV and JCV large T antigen-specific CD8(+) T-cell response in HLA A*0201(+) kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008 42 : 198 202.
22. Binggeli S, Egli A, Schaub S et al. Polyomavirus BK-Specific Cellular Immune Response to VP1 and Large T-Antigen in Kidney Transplant Recipients. Am J Transplant 2007 7 : 1131 1139.
23. Luo C, Bueno M, Kant J, Martinson J, Randhawa P. Genotyping Schemes for Polyomavirus BK using Gene Specific Phylogenetic Trees and SNP Analysis. J Virol 2008 83 : 2285 2297.
24. Luo C, Bueno M, Kant J, Randhawa P. Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories. J Med Virol 2008 80 : 1850 1857.
25. Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995 26 : 671 673.
26. Bodaghi S, Comoli P, Boesch R et al. Antibody Responses to Recombinant Polyomavirus BK Large T and VP1 Proteins in Pediatric Kidney Transplant Patients. J Clin Micro 2009 47 : 2577 2585.
27. Comoli P, Azzi A, Maccario R et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004 78 : 1229 1232.
28. Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008 13 : 569 574.
29. Jin L, Gibson PE, Knowles WA, Clewley JP. BK virus antigenic variants: sequence analysis within the capsid VP1 epitope. J Med Virol 1993 39 : 50 56.
30. Knowles WA, Pipkin P, Andrews N et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003 71 : 115 123.
31. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973 128 : 784 787.
32. Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002 73 : 1090 1094.
33. Egli A, Dumoulin A, Köhli S, Hirsch HH. Polyomavirus BK after kidney transplantation-Role of molecular and immunological markers. Trends Transplant 2009 3 : 85 102.
34. Randhawa PS, Gupta G, Vats A, Shapiro R, Viscidi RP. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 2006 13 : 1057 1063.
35. Randhawa P, Viscid R, Carter JJ et al. Identification of species-specific and cross reactive epitopes in human polyomavirus capsids using monoclonal antibodies. J Gen Virol 2009 90 : 634 639.
36. Egli A, Infanti L, Dumoulin A et al. Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors. J Infect Dis 2009 199 : 837 846.
37. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983 147 : 676 684.
38. Egli A, Koehli S, Dickenmann M, Hirsch HH. Inhibition of Polyomavirus BK- and Cytomegalovirus-specific T-cell responses by immunosuppressive drugs. Transplantation 2009 88 : 1161 1168.
39. Brennan DC, Agha I, Bohl DL et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005 5 : 582 594.
40. Randhawa P, Uhrmacher J, Pasculle W et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005 77 : 238 243.
41. Funk GA, Gosert R, Comoli P, Ginevri F, Hirsch HH. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008 8 : 2368 2377.
42. Nickeleit V, Hirsch HH, Binet IF et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999 10 : 1080 1089.
43. Drachenberg CB, Beskow CO, Cangro CB et al. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol 1999 30 : 970 977.
44. Drachenberg RC, Drachenberg CB, Papadimitriou JC et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 2001 1 : 373 381.
45. Thomas LD, Vilchez RA, White ZS et al. A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis 2007 195 : 442 449.
46. Doucette KE, Pang XL, Jackson K et al. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation 2008 85 : 1733 1736.
47. Haririan A, Ramos ER, Drachenberg CB, Weir MR, Klassen DK. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002 73 : 1350 1353.
48. Barber CE, Hewlett TJ, Geldenhuys L, Kiberd BA, Acott PD, Hatchette TF. BK virus nephropathy in a heart transplant recipient: Case report and review of the literature. Transpl Infect Dis 2006 8 : 113 121.
49. Bohl DL, Storch GA, Ryschkewitsch C et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005 5 : 2213 2221.
50. Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000 342 : 1309 1315.
51. Drachenberg CB, Hirsch HH, Papadimitriou JC et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: A prospective evaluation. Transplantation 2007 84 : 323 330.
52. Viscount HB, Eid AJ, Espy MJ et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 2007 84 : 340 345.
53. Drachenberg CB, Papadimitriou JC, Hirsch HH et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004 4 : 2082 2092.
54. Wadei HM, Rule AD, Lewin M et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006 6 (5 Pt 1 1025 1032.
55. Drachenberg CB, Papadimitriou JC, Wali R et al. Improved outcome of polyoma virus allograft nephropathy with early biopsy. Transplant Proc 2004 36 : 758 759.
56. Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007 22 : 1243 1250.
57. Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation 2009 87 : 1019 1026.
58. Schold JD, Rehman S, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transplant Int 2009 22 : 626 634.
59. Hirsch HH, Friman S, Wiecek A, Rostaing L, Pescovitz M. Prospective study of polyomavirus BK viruria and viremia in de novo renal transplantation (Abstract 77). Am J Transplant 2007 7 (Suppl.5 150.
60. Manitpisitkul W, Drachenberg C, Ramos E et al. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation 2009 88 : 83 88.
61. Prince O, Savic S, Dickenmann M, Steiger J, Bubendorf L, Mihatsch MJ. Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant 2009 24 : 1024 1033.
62. Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transplant Infect Dis 2006 8 : 86 94.
63. Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 2000 66 : 238 245.
64. Ding R, Suthanthiran M. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine. Transplantation 2003 76 : 446.
65. Singh HK, Andreoni KA, Madden V et al. Presence of urinary haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol 2009 20 : 416 427.
66. Buehrig CK, Lager DJ, Stegall MD et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003 64 : 665 673.
67. Batal I, Franco ZM, Shapiro R et al. Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. Hum Pathol 2009 40 : 1312 1319.
68. McGilvray ID, Lajoie G, Humar A, Cattral MS. Polyomavirus infection and acute vascular rejection in a kidney allograft: Coincidence or mimicry? Am J Transplant 2003 3 : 501 504.
69. Petrogiannis-Haliotis T, Sakoulas G, Kirby J et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001 345 : 1250 1255.
70. Nickeleit V, Hirsch HH, Zeiler M et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000 15 : 324 332.
71. Schaub S, Mayr M, Egli A et al. Transient allograft dysfunction from immune reconstitution in a patient with polyoma BK-virus-associated nephropathy. Nephrol Dial Transplant 2007 22 : 2386 2390.
72. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005 68 : 1834 1839.
73. Saad ER, Bresnahan BA, Cohen EP et al. Successful Treatment of BK Viremia Using Reduction in Immunosuppression Without Antiviral Therapy. Transplantation 2008 85 : 850 854.
74. Wali RK, Drachenberg CB, Hirsch HH et al. Intensive versus routine care screening for polyoma viral replication (cluster randomization) and a road map for stepwise modification of immunosuppression therapy (Abstract). Am J Transplant 2008 8 (supl 2 283.
75. Ginevri F, Azzi A, Hirsch HH et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007 7 : 2727 2735.
76. Wu SW, Chang HR, Hsieh MC, Chiou HL, Lin CC, Lian JD. Early diagnosis of polyomavirus type BK infection in tailoring immunosuppression for kidney transplant patients: screening with urine qualitative polymerase chain reaction assay. Transplant Proc 2008 40 : 2389 2391.
77. Almeras C, Foulongne V, Garrigue V et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 2008 85 : 1099 1104.
78. Ahn HJ, Ju MK, Jeong HJ et al. Immunologic control for polyomavirus infection after kidney transplantation. Nephron Clin Pract 2008 108 : c148 c154.
79. Hymes LC, Greenbaum L, Amaral SG, Warshaw BL. Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients. Pediatr Transplant 2007 11 : 536 539.
80. Giraldi C, Noto A, Tenuta R et al. Prospective study of BKV nephropathy in 117 renal transplant recipients. New Microbiol 2007 30 : 127 130.
81. Farasati NA, Shapiro R, Vats A, Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005 79 : 116 118.
82. Bernhoff E, Gutteberg TJ, Sandvik K, Hirsch HH, Rinaldo CH. Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression. Am J Transplant 2008 8 : 1413 1422.
83. Vats A, Shapiro R, Singh Randhawa P et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003 75 : 105 112.
84. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant 2008 12 : 790 795.
85. Josephson MA, Gillen D, Javaid B et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006 81 : 704 710.
86. Wu SW, Chang HR, Lian JD. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 2008 24 : 1034 1038.
87. Rinaldo CH, Hirsch HH. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti Infect Ther 2007 5 : 105 115.
88. Kuypers DR, Vandooren AK, Lerut E et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005 5 : 1997 2004.
89. Kuypers DR, Bammens B, Claes K, Evenepoel P, Lerut E, Vanrenterghem Y. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J Antimicrob Chemother 2009 63 : 417 419.
90. Lopez V, Sola E, Gutierrez C et al. Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy. Transplant Proc 2006 38 : 2412 2413.
91. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis 2006 8 : 95 101.
92. Williams JW, Javaid B, Kadambi PV et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005 352 : 1157 1158.
93. Faguer S, Hirsch HH, Kamar N et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 2007 20 : 962 969.
94. Sener A, House AA, Jevnikar AM et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 2006 81 : 117 120.
95. Mayr M, Nickeleit V, Hirsch HH, Dickenmann M, Mihatsch MJ, Steiger J. Polyomavirus BK nephropathy in a kidney transplant recipient: Critical issues of diagnosis and management. Am J Kidney Dis 2001 38 : E13.
96. Kayler LK, Mohanka R, Morgan C, Basu A, Shapiro R, Randhawa PS. Clinical course of kidney transplant patients with acute rejection and BK virus replication following Campath therapy. Clin Transplant 2008.
97. Womer KL, Guerra G, Dibadj K et al. Immunosuppression reduction for BK virus nephropathy: a case for caution. Transpl Infect Dis 2007 9 : 244 248.
98. Kayler LK, Batal I, Mohanka R et al. Antirejection treatment in kidney transplant patients with BK viruria. Transplantation 2008 86 : 797 803.
99. Yeo FE, Yuan CM, Swanson SJ et al. The prevalence of BK polyomavirus infection in outpatient kidney transplant recipients followed in a single center. Clin Transplant 2008 22 : 532 541.
100. Drachenberg C, Hirsch HH, Papadimitriou JC et al. Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy. Transplant Proc 2004 36 : 3028 3031.
101. Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005 5 : 1926 1933.
102. Pang XL, Doucette K, LeBlanc B, Cockfield SM, Preiksaitis JK. Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: One-year prospective study. J Clin Microbiol 2007 45 : 3568 3573.
103. Hymes LC, Warshaw BL. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006 10 : 920 922.
104. Hirsch HH, Drachenberg CB, Steiger J, Ramos E. Polyomavirus-associated nephropathy in renal transplantation: Critical issues of screening and management. Adv Exp Med Biol 2006 577 : 160 173.
105. Randhawa P, Vats A, Shapiro R. Monitoring for polyomavirus BK And JC in urine: comparison of quantitative polymerase chain reaction with urine cytology. Transplantation 2005 79 : 984 986.
106. Koukoulaki M, O'Donovan M, Pursglove S, Alexopoulou D, Hadjiconstantinou V, Drakopoulos S. Prospective study of urine cytology screening for BK polyoma virus replication in renal transplant recipients. Cytopathology 2008 19 : 385 388.
107. Kiberd BA. Screening to prevent polyoma virus nephropathy: A medical decision analysis. Am J Transplant 2005 5 : 2410 2416.
108. Smith F, Panek R, Kiberd BA. Screening to prevent polyoma virus nephropathy in kidney transplantation: A Cost Analysis. Am J Transplant 2009 9 : 2177 2179.
109. Hirsch HH, Ramos E. Retransplantation after polyomavirus-associated nephropathy: just do it? Am J Transplant 2006 6 : 7 9.
110. Womer KL, Meier-Kriesche HU, Patton PR et al. Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia. Am J Transplant 2006 6 : 209 213.
111. Mindlova M, Boucek P, Saudek F et al. Kidney retransplantation following graft loss to polyoma virus-associated nephropathy: an effective treatment option in simultaneous pancreas and kidney transplant recipients. Transpl Int 2008 21 : 353 356.
112. Hamilton RS, Gravell M, Major EO. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol 2000 38 : 105 109.
113. Ginevri F, De Santis R, Comoli P et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003 75 : 1266 1270.
114. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004 4 : 2109 2117.
115. Randhawa P, Bohl D, Brennan D et al. Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 2008 15 : 1564 1571.
116. Andrews CA, Shah KV, Daniel RW, Hirsch MS, Rubin RH. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 1988 158 : 176 181.
117. Hariharan S, Cohen EP, Vasudev B et al. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant 2005 5 : 2719 2724. (Pubitemid 43920066)
118. Leuenberger D, Andresen PA, Gosert R et al. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clin Vaccine Immunol 2007 14 : 959 968.
119. Bohl DL, Brennan DC, Ryschkewitsch C, Gaudreault-Keener M, Major EO, Storch GA. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 2008 43 : 184 189.
120. Haririan A, Hamze O, Drachenberg CB, Ramos E, Weir MR, Klassen DK. Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients. Transplantation 2003 75 : 1186 1190.
121. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis 2005 192 : 1349 1354.
122. Schmid H, Burg M, Kretzler M, Banas B, Grone HJ, Kliem V. BK virus associated nephropathy in native kidneys of a heart allograft recipient. Am J Transplant 2005 5 : 1562 1568.
123. Schwarz A, Mengel M, Haller H, Niedermeyer J. Polyoma virus nephropathy in native kidneys after lung transplantation. Am J Transplant 2005 5 : 2582 2585.
124. Barton TD, Blumberg EA, Doyle A et al. A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction. Transpl Infect Dis 2006 8 : 102 107.
125. Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 2009 87 : 621 630.